🇬🇧

Johnson & Johnson hit as jury awards 'excessive' $8 billion in damages

Credit: Reuters- Published on October 9, 2019
Shares of Johnson & Johnson dipped 2% on Wednesday after a jury awarded $8 billion in punitive damages to a man who accused the drugmaker of failing to warn that young men using its antipsychotic drug Risperdal could grow breasts.
Advertisement

Credit: WJZ Baltimore
Published on October 9, 2019 -  00:25
Johnson & Johnson Ordered To Pay $8 Billion To Maryland Man
A jury found that Johnson & Johnson failed to warn 26-year-old Nicholas Murray, of Maryland, of the drug's side effects. Murray claimed that taking the Risperdal as a child caused him to develop breasts, an incurable condition known as gynecomastia. Thousands of others have filed lawsuits alleging the same.

You are here

Recent related videos from verified sources

Man who grew breasts after taking autism drug wins billions in damages 01:06
Credit: Wibbitz - Bang Entertainment - Published on October 10, 2019 


Man grows jugs after taking Johnson and Johnson drugs 01:42
Credit: TomoNews US - Published on October 10, 2019 


$8 Billion Judgement Against Johnson & Johnson 00:34
Credit: CBS 3 Philly - Published on October 10, 2019 


Philadelphia Jury Issues $8 Billion Judgement Against Johnson & Johnson Over Drug Linked To Male Breast Growth 00:27
Credit: CBS 3 Philly - Published on October 9, 2019 


J&J hit by "excessive" $8 bln verdict 01:15
Credit: Rumble - Published on October 9, 2019 


Drugmakers in spotlight as GSK recalls Zantac 01:18
Credit: Reuters Studio - Published on October 9, 2019 


Johnson & Johnson Agrees to $20.4 Million Opioid Settlement 01:07
Credit: Wibbitz Top Stories - Published on October 2, 2019 


You might like